Neurostimulation Devices – Market Insights – Europe

Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on expanding into new indications, increasing the population treatable with these devices, although limited reimbursement and increasing competition from noninvasive alternatives will hinder the pace of market growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for neurostimulation devices in Europe from 2019 through 2032.

The European neurostimulation device market will grow modestly over the forecast period.

Which segments will see the strongest growth through 2032?

What factors will drive growth in the overall market?

What factors are hampering growth of the overall market?

New products in a number of device segments have entered the market recently.

How do new-generation products compare to previous devices? Which barriers to adoption do they address?

Through which novel technologies are competitors differentiating their devices?

How is the launch of new products affecting the competitive landscape?

New indications remain a key area of focus in a number of market segments.

In which emerging indications have approvals recently been granted, and to which companies?

In which other indications have the most developments and clinical progress been made?

Table of contents